FDA Approval Summary: Vemurafenib for Treatment of Unresectable or Metastatic Melanoma with the BRAFV600E MutationGeoffrey Kim, Richard Pazdur, Amy E. McKee et al.|Clinical Cancer Research|2014Cited by 215
FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspectiveJane P. F. Bai, Hao Zhu, Brian J. Schmidt et al.|The AAPS Journal|2021Cited by 38
Esomeprazole FDA Approval in Children With GERDJustin Earp, Christine Garnett, Marie Sandström et al.|Journal of Pediatric Gastroenterology and Nutrition|2016Cited by 14
Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug DevelopmentGeorgi I. Kapitanov, Piet H. van der Graaf, Justin Earp et al.|Clinical Pharmacology & Therapeutics|2025Cited by 3